Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination

We report the case of a 19-year-old male who complained of myalgia, muscle weakness, and darkened urine two days after receiving his Ad26.COV2.S (Johnson & Johnson, New Brunswick, New Jersey, United States) COVID-19 vaccination. Blood examination revealed an increased creatine kinase (CK) level,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelbenegger, Georg, Cacioppo, Filippo, Firbas, Christa, Jilma, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472996/
https://www.ncbi.nlm.nih.gov/pubmed/34579193
http://dx.doi.org/10.3390/vaccines9090956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472996/
https://www.ncbi.nlm.nih.gov/pubmed/34579193
http://dx.doi.org/10.3390/vaccines9090956

Ejemplares similares